We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ENTOD Pharmaceuticals announced its commitment to offer financial support to 250 under-privileged glaucoma patients to ensure they have lifetime access to critical glaucoma medicines.